Tevogen Bio Holdings Inc.
For the period ended Feb 19, 2026. Filed Feb 25, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Feb 19, 2026 · Filed Feb 25, 2026
Use the contents to explore the available documents and sections.
TVGN$5.59+0.5%Stored close · as of Nov 6, 2026
Contents
Proposal No. 2 - Reverse Stock Split Proposal
| For | Against | Abstentions | Broker Non-Votes |
|---|---|---|---|
| 176,344,447 | 6,042,353 | 25,717 | - |
Item 9.01 Financial Statements and Exhibits.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.